Journal of Medicinal Chemistry · 2018 · 16 citations · 16 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsCytochrome P450 EnzymesDrug-metabolizing EnzymesMetabolite IdentificationReactive Metabolite FormationReactive MetabolitesStructure-activity Relationship AnalysisCytochrome P450 3A4 MetabolismCytochrome P450 BioactivationCytochrome P450 Enzyme ActivityCytochrome P450 Metabolite IdentificationCytochrome P450 Structure-function RelationshipsOxidative BiotransformationTime-dependent Enzyme InhibitionTime-dependent Inhibition
Herein we describe structure-activity relationship (SAR) and metabolite identification (Met-ID) studies that provided insight into the origin of time-dependent inhibition (TDI) of cytochrome P450 3A4 (CYP3A4) by compound 1. Collectively, these efforts revealed that bioactivation of the fluoropyrimidine moiety of 1 led to reactive metabolite formation via oxidative defluorination and was responsible for the observed TDI. We discovered that substitution at both the 4- and 6-positions of the 5-fluoropyrimidine of 1 was necessary to ameliorate this TDI as exemplified by compound 19.
16
Jared N. Cumming, Elizabeth M. Smith, Lingyan Wang et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 154 citations · Full text
Zhaoning Zhu, Z. J. Sun, Yuanzan Ye et al. · Journal of Medicinal Chemistry · 2009 · 121 citations · Full text
Yu‐Sen Wang, Corey Strickland, Johannes Voigt et al. · Journal of Medicinal Chemistry · 2009 · 101 citations · Full text